AZACITIDINE AQVIDA
25MG/ML INJ PLV SUS 1X100MG
SÚKL code | 0242739 |
---|---|
Name of the product | AZACITIDINE AQVIDA |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | AZACITIDINE AQVIDA |
Supplement | 25MG/ML INJ PLV SUS 1X100MG |
Strenght | 25MG/ML |
Pharmaceutical form | Powder for suspension for injection |
Package | 1X100MG |
Route | Subcutaneous use |
Language of the pack | Czech |
Wrap type | Vial |
Legal status | na lékařský předpis |
Active substance | AZACITIDINE (AZACITIDINUM) |
ATC group | L01BC07 |
ATC group name | AZACITIDIN |
Marketing authorisation information
Registration Number | 44/ 120/19-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 12. 2021 |
MA Holder | AqVida GmbH, Hamburg |
MA Holder country | NĚMECKO |
Actual MA holder | EVER-Valinject GmbH, Unterach am Attersee |
Actual MA holder country | RAKOUSKO |